Avid Bioservices Inc (CDMO)

[Robert C Jonson]

" I believe FTM is saying that if the current 2nd line trial is deemed to be statistically significant for the outstanding MOS data then there is a possibility to achieve regular approval vice accelerated approval"

I agree that's what he's saying and I'm saying regular approval takes longer than accelerated approval. So if Bavi gives stat. sig. results it's going to take longer to get approved than if it doesn't? Doesn't seem right or desirable.